Our Science – Wiltrout Website
Robert H. Wiltrout, Ph.D.
Selected Publications |
 |
| 1)
Xiao Z, Jiang Q, Willette-Brown J, Xi S, Zhu F, Burkett S, Back T, Song NY, Datla M, Sun Z, Goldszmid R, Lin F, Cohoon T, Pike K, Wu X, Schrump DS, Wong KK, Young HA, Trinchieri G, Wiltrout RH, Hu Y. The Pivotal Role of IKKa in the Development of Spontaneous Lung Squamous Cell Carcinomas. Cancer Cell. 23: 527-40, 2013. [Journal] |
|
| 2)
Jiang Q, Weiss JM, Wiltrout RH. A matched couple: Combining kinase inhibitors with immunotherapy for cancer treatment. Oncoimmunology. 1: 115-117, 2012. [Journal] |
|
| 3)
Stauffer JK, Scarzello AJ, Jiang Q, Wiltrout RH. Chronic inflammation, immune escape and oncogenesis in the liver: A unique neighborhood for novel intersections. Hepatology. 56: 1567-74, 2012. [Journal] |
|
| 4)
Tietze JK, Wilkins DE, Sckisel GD, Bouchlaka MN, Alderson KL, Weiss JM, Ames E, Bruhn KW, Craft N, Wiltrout RH, Longo DL, Lanier LL, Blazar BR, Redelman D, Murphy WJ. Delineation of antigen-specific and antigen-nonspecific CD8+ memory T-cell responses after cytokine-based cancer immunotherapy. Blood. 119: 3073-83, 2012. [Journal] |
|
| 5)
Okayama H, Saito M, Oue N, Weiss JM, Stauffer J, Takenoshita S, Wiltrout RH, Perwez Hussain S, Harris CC. NOS2 enhances KRAS-induced lung carcinogenesis, inflammation and microRNA-21 expression. Int J Cancer. 132: 9-18, 2012. [Journal] |
|
| 6)
Chan T, Back TC, Subleski JJ, Weiss JM, Ortaldo JR, Wiltrout RH. Systemic IL-12 administration alters hepatic dendritic cell stimulation capabilities. PLoS ONE. 7: e33303, 2012. [Journal] |
|
| 7)
Stauffer JK, Scarzello AJ, Andersen JB, De Kluyver RL, Back TC, Weiss JM, Thorgeirsson SS, Wiltrout RH. Coactivation of AKT and β-catenin in mice rapidly induces formation of lipogenic liver tumors. Cancer Res. 71: 2718-27, 2011. [Journal] |
|
| 8)
Barao I, Alvarez M, Redelman D, Weiss JM, Ortaldo JR, Wiltrout RH, Murphy WJ. Hydrodynamic delivery of human IL-15 cDNA increases murine natural killer cell recovery after syngeneic bone marrow transplantation. Biol. Blood Marrow Transplant. 17: 1754-64, 2011. [Journal] |
|
| 9)
Chan T, Wiltrout RH, Weiss JM. Immunotherapeutic modulation of the suppressive liver and tumor microenvironments. Int Immunopharmacol. 11: 879-89, 2011. [Journal] |
|
| 10)
Jiang Q, Weiss JM, Back T, Chan T, Ortaldo JR, Guichard S, Wiltrout RH. mTOR Kinase Inhibitor AZD8055 Enhances the Immunotherapeutic Activity of an Agonist CD40 Antibody in Cancer Treatment. Cancer Res. 71: 4074-84, 2011. [Journal] |
|
| Click Here to View Expanded Bibliography. |
This page was last updated on 5/3/2013.
